{"transactions":[{"id":4624138,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-18T22:00:03.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":3992,"price":199.3032,"value":795618.3744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,650 restricted stock units."}],"balance_after":119216,"source":{"system":"sec-edgar","filing":"0001800668-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000180066826000007/ownership.xml","form_type":"4"}},{"id":4624137,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-18T22:00:03.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":61,"price":195,"value":11895.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."}],"balance_after":123208,"source":{"system":"sec-edgar","filing":"0001800668-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000180066826000007/ownership.xml","form_type":"4"}},{"id":725554,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:10:03.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026."}],"balance_after":20600,"derivative":{"exercise_price":18.56,"exercise_date":"2026-03-01","expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000296/form4.xml","form_type":"4"}},{"id":725553,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T20:10:03.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":300,"price":170.32,"value":51096.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $169.81 to $170.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,388 restricted stock units."}],"balance_after":123269,"source":{"system":"sec-edgar","filing":"0001610717-26-000296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000296/form4.xml","form_type":"4"}},{"id":725552,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T20:10:03.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":5651,"price":169.2441,"value":956398.4091,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $168.78 to $169.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,388 restricted stock units."}],"balance_after":123569,"source":{"system":"sec-edgar","filing":"0001610717-26-000296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000296/form4.xml","form_type":"4"}},{"id":725551,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T20:10:03.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":9496,"price":168.1959,"value":1597188.2664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $167.77 to $168.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,388 restricted stock units."}],"balance_after":129220,"source":{"system":"sec-edgar","filing":"0001610717-26-000296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000296/form4.xml","form_type":"4"}},{"id":725550,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T20:10:03.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":4553,"price":167.345,"value":761921.785,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $166.76 to $167.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,388 restricted stock units."}],"balance_after":138716,"source":{"system":"sec-edgar","filing":"0001610717-26-000296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000296/form4.xml","form_type":"4"}},{"id":725549,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-26T20:10:03.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":18.56,"value":371200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,388 restricted stock units."}],"balance_after":143269,"source":{"system":"sec-edgar","filing":"0001610717-26-000296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000296/form4.xml","form_type":"4"}},{"id":732177,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-18T20:10:24.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":2722,"price":156.1192,"value":424956.4624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8251. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 51,388 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 479 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":123269,"source":{"system":"sec-edgar","filing":"0001610717-26-000244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000244/form4.xml","form_type":"4"}},{"id":833561,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:55:28.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":2753,"price":99.4804,"value":273869.5412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 56,600 RSUs."}],"balance_after":125512,"source":{"system":"sec-edgar","filing":"0001610717-26-000128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000128/form4.xml","form_type":"4"}},{"id":867771,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T02:07:14.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":45400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":45400,"derivative":{"exercise_price":102.02,"expiration_date":"2036-02-28","underlying":"Common Stock","underlying_shares":45400},"source":{"system":"sec-edgar","filing":"0001610717-26-000079","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000079/form4.xml","form_type":"4"}},{"id":867770,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T02:07:14.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 62,538 restricted stock units."}],"balance_after":128265,"source":{"system":"sec-edgar","filing":"0001610717-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000079/form4.xml","form_type":"4"}},{"id":942219,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T21:20:21.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."}],"balance_after":15900,"derivative":{"exercise_price":42.45,"exercise_date":"2025-03-04","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-26-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000012/form4.xml","form_type":"4"}},{"id":942218,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:21.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":98,"value":980000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 42,338 restricted stock units."}],"balance_after":108065,"source":{"system":"sec-edgar","filing":"0001610717-26-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000012/form4.xml","form_type":"4"}},{"id":942217,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:21.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":42.45,"value":424500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 42,338 restricted stock units."}],"balance_after":118065,"source":{"system":"sec-edgar","filing":"0001610717-26-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071726000012/form4.xml","form_type":"4"}},{"id":963201,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-18T21:15:23.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":3104,"price":77.0904,"value":239288.6016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 175 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 42,338 restricted stock units."}],"balance_after":108065,"source":{"system":"sec-edgar","filing":"0001610717-25-000420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000420/form4.xml","form_type":"4"}},{"id":987215,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T21:16:15.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":5418,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":17,"exercise_date":"2024-02-12","expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":5418},"source":{"system":"sec-edgar","filing":"0001610717-25-000404","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000404/form4.xml","form_type":"4"}},{"id":987214,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:16:15.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":5418,"price":74,"value":400932.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,275 restricted stock units."}],"balance_after":110994,"source":{"system":"sec-edgar","filing":"0001610717-25-000404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000404/form4.xml","form_type":"4"}},{"id":987213,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:16:15.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":5418,"price":17,"value":92106.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,275 restricted stock units."}],"balance_after":116412,"source":{"system":"sec-edgar","filing":"0001610717-25-000404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000404/form4.xml","form_type":"4"}},{"id":1000323,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-13T21:20:35.000Z","date":"2025-11-11","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5418,"derivative":{"exercise_price":17,"exercise_date":"2024-02-12","expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-25-000377","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000377/form4.xml","form_type":"4"}},{"id":1000322,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:20:35.000Z","date":"2025-11-11","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":64,"value":640000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,275 restricted stock units."}],"balance_after":110994,"source":{"system":"sec-edgar","filing":"0001610717-25-000377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000377/form4.xml","form_type":"4"}},{"id":1000321,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:20:35.000Z","date":"2025-11-11","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":17,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,275 restricted stock units."}],"balance_after":120994,"source":{"system":"sec-edgar","filing":"0001610717-25-000377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000377/form4.xml","form_type":"4"}},{"id":1036385,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-18T20:34:56.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":2320,"price":45.8249,"value":106313.768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,275 restricted stock units."}],"balance_after":110994,"source":{"system":"sec-edgar","filing":"0001610717-25-000346","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000346/form4.xml","form_type":"4"}},{"id":1048041,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":false,"shares":2049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."}],"balance_after":15418,"derivative":{"exercise_price":17,"exercise_date":"2024-02-12","expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":2049},"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048040,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":false,"shares":3189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."}],"balance_after":0,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":3189},"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048039,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":1948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."}],"balance_after":3189,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":1948},"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048038,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":2814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."}],"balance_after":0,"derivative":{"exercise_price":2.68,"exercise_date":"2022-08-16","expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":2814},"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048037,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":5238,"price":40.1742,"value":210432.4596,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $40.01 to $40.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,213 RSUs."}],"balance_after":113314,"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048036,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":true,"shares":2049,"price":17,"value":34833.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,213 RSUs."}],"balance_after":118552,"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048035,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":true,"shares":3189,"price":4.73,"value":15083.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,213 RSUs."}],"balance_after":116503,"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048034,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":4762,"price":40.0168,"value":190560.0016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $40.00 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,213 RSUs."}],"balance_after":113314,"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048033,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":1948,"price":4.73,"value":9214.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,213 RSUs."}],"balance_after":118076,"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1048032,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:05:35.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":2814,"price":2.68,"value":7541.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,213 RSUs."}],"balance_after":116128,"source":{"system":"sec-edgar","filing":"0001610717-25-000326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000326/form4.xml","form_type":"4"}},{"id":1106391,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-18T20:05:51.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":2170,"price":39.83,"value":86431.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $39.5913 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 478 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 54,213 RSUs."}],"balance_after":113314,"source":{"system":"sec-edgar","filing":"0001610717-25-000239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000239/form4.xml","form_type":"4"}},{"id":1197177,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-19T21:42:31.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":1864,"price":39.0403,"value":72771.1192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,150 RSUs."}],"balance_after":115006,"source":{"system":"sec-edgar","filing":"0001610717-25-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000079/form4.xml","form_type":"4"}},{"id":1228999,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:02:51.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":71400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":71400,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":71400},"source":{"system":"sec-edgar","filing":"0001610717-25-000055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000055/form4.xml","form_type":"4"}},{"id":1228998,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:02:51.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 65,276 restricted stock units."}],"balance_after":116870,"source":{"system":"sec-edgar","filing":"0001610717-25-000055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071725000055/form4.xml","form_type":"4"}},{"id":1326813,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:06:52.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":2635,"price":45.4038,"value":119639.013,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 173 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 44,876 RSUs."}],"balance_after":96470,"source":{"system":"sec-edgar","filing":"0001610717-24-000543","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000543/form4.xml","form_type":"4"}},{"id":1386723,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-15T21:30:08.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 14, 2024."}],"balance_after":2814,"derivative":{"exercise_price":2.68,"exercise_date":"2022-08-16","expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-24-000507","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000507/form4.xml","form_type":"4"}},{"id":1386722,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-15T21:30:08.000Z","date":"2024-10-11","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":50.2979,"value":502979.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $50.00 to $50.78, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50,000 restricted stock units."}],"balance_after":98932,"source":{"system":"sec-edgar","filing":"0001610717-24-000507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000507/form4.xml","form_type":"4"}},{"id":1386721,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-15T21:30:08.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.68,"value":26800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50,000 restricted stock units."}],"balance_after":108932,"source":{"system":"sec-edgar","filing":"0001610717-24-000507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000507/form4.xml","form_type":"4"}},{"id":1403669,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:18:34.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":2244,"price":44.1853,"value":99151.8132,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50,000 RSUs."}],"balance_after":98932,"source":{"system":"sec-edgar","filing":"0001610717-24-000489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000489/form4.xml","form_type":"4"}},{"id":1473273,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-20T20:13:40.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":1893,"price":37.3876,"value":70774.7268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $37.3869 to $37.3887, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,110 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 55,126 RSUs."}],"balance_after":101176,"source":{"system":"sec-edgar","filing":"0001610717-24-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000351/form4.xml","form_type":"4"}},{"id":1528446,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T23:36:38.000Z","date":"2024-05-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023."}],"balance_after":12814,"derivative":{"exercise_price":2.68,"exercise_date":"2022-08-16","expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-24-000229","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000229/form4.xml","form_type":"4"}},{"id":1528445,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-03T23:36:38.000Z","date":"2024-05-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":40.026,"value":400260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $40.00 to $40.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,250 restricted stock units."}],"balance_after":101959,"source":{"system":"sec-edgar","filing":"0001610717-24-000229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000229/form4.xml","form_type":"4"}},{"id":1528444,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-03T23:36:38.000Z","date":"2024-05-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.68,"value":26800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,250 restricted stock units."}],"balance_after":111959,"source":{"system":"sec-edgar","filing":"0001610717-24-000229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000229/form4.xml","form_type":"4"}},{"id":1566100,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-20T20:43:59.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":1261,"price":31.5832,"value":39826.4152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 60,250 RSUs."}],"balance_after":101959,"source":{"system":"sec-edgar","filing":"0001610717-24-000170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000170/form4.xml","form_type":"4"}},{"id":1596870,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T21:53:11.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":92400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":92400,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":92400},"source":{"system":"sec-edgar","filing":"0001610717-24-000130","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000130/form4.xml","form_type":"4"}},{"id":1596869,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:53:11.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 63,726 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 404 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023."}],"balance_after":103220,"source":{"system":"sec-edgar","filing":"0001610717-24-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071724000130/form4.xml","form_type":"4"}},{"id":1703411,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-20T22:10:14.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":1775,"price":25.9018,"value":45975.695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $25.9017 to $25.9385, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,326 RSUs."}],"balance_after":76416,"source":{"system":"sec-edgar","filing":"0001610717-23-000416","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000416/form4.xml","form_type":"4"}},{"id":1756247,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-23T22:01:14.000Z","date":"2023-10-23","kind":"exercise","planned":false,"acquired":false,"shares":5137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5137},"source":{"system":"sec-edgar","filing":"0001610717-23-000313","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000313/form4.xml","form_type":"4"}},{"id":1756246,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-23T22:01:14.000Z","date":"2023-10-23","kind":"exercise","planned":false,"acquired":false,"shares":19387,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22814,"derivative":{"exercise_price":2.68,"exercise_date":"2022-08-16","expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":19387},"source":{"system":"sec-edgar","filing":"0001610717-23-000313","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000313/form4.xml","form_type":"4"}},{"id":1756245,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-23T22:01:14.000Z","date":"2023-10-23","kind":"exercise","planned":false,"acquired":true,"shares":5137,"price":4.09,"value":21010.33,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 40,800 restricted stock units."}],"balance_after":78191,"source":{"system":"sec-edgar","filing":"0001610717-23-000313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000313/form4.xml","form_type":"4"}},{"id":1756244,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-23T22:01:14.000Z","date":"2023-10-23","kind":"exercise","planned":false,"acquired":true,"shares":19387,"price":2.68,"value":51957.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 40,800 restricted stock units."}],"balance_after":73054,"source":{"system":"sec-edgar","filing":"0001610717-23-000313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000313/form4.xml","form_type":"4"}},{"id":1776285,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-20T20:11:07.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":1427,"price":31.3106,"value":44680.2262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $31.101 to $31.3108, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 40,800 restricted stock units."}],"balance_after":53667,"source":{"system":"sec-edgar","filing":"0001610717-23-000292","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000292/form4.xml","form_type":"4"}},{"id":1787336,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-07T00:02:45.000Z","date":"2023-09-01","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023."}],"balance_after":42201,"derivative":{"exercise_price":2.68,"exercise_date":"2022-08-16","expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-23-000259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000259/form4.xml","form_type":"4"}},{"id":1787335,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T00:02:45.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":35.0546,"value":701092.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $35.00 to $35.24, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,276 restricted stock units."}],"balance_after":55094,"source":{"system":"sec-edgar","filing":"0001610717-23-000259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000259/form4.xml","form_type":"4"}},{"id":1787334,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T00:02:45.000Z","date":"2023-09-01","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":2.68,"value":53600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person adopted on March 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,276 restricted stock units."}],"balance_after":75094,"source":{"system":"sec-edgar","filing":"0001610717-23-000259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000259/form4.xml","form_type":"4"}},{"id":1846608,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-22T20:25:29.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":1249,"price":24.891,"value":31088.859,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,110 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 44,276 RSUs."}],"balance_after":55094,"source":{"system":"sec-edgar","filing":"0001610717-23-000193","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000161071723000193/form4.xml","form_type":"4"}},{"id":1943172,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-22T00:33:31.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":665,"price":21.78,"value":14483.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.4075 to $21.784581, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 47,750 RSUs."}],"balance_after":55233,"source":{"system":"sec-edgar","filing":"0000899243-23-009376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000089924323009376/doc4.xml","form_type":"4"}},{"id":1974123,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:17:38.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":93100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":93100,"derivative":{"exercise_price":26.5,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":93100},"source":{"system":"sec-edgar","filing":"0001567619-23-004356","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761923004356/doc1.xml","form_type":"4"}},{"id":1974122,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:17:38.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":26600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 49,563 restricted stock units."}],"balance_after":55898,"source":{"system":"sec-edgar","filing":"0001567619-23-004356","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761923004356/doc1.xml","form_type":"4"}},{"id":2078864,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-21T21:08:00.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":658,"price":22.9405,"value":15094.849,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $22.4716 to $22.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,964 RSUs."}],"balance_after":29298,"source":{"system":"sec-edgar","filing":"0001567619-22-021930","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922021930/doc1.xml","form_type":"4"}},{"id":2153509,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-21T20:17:09.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":449,"price":19.0426,"value":8550.1274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $18.98 to $19.0337, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 24,776 RSUs."}],"balance_after":29956,"source":{"system":"sec-edgar","filing":"0001567619-22-017689","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922017689/doc1.xml","form_type":"4"}},{"id":2167760,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T20:18:21.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 1, 2022 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":21.61,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001567619-22-016989","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922016989/doc1.xml","form_type":"4"}},{"id":2167759,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-02T20:18:21.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 25,964 restricted stock units."}],"balance_after":30405,"source":{"system":"sec-edgar","filing":"0001567619-22-016989","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922016989/doc1.xml","form_type":"4"}},{"id":2224231,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-22T21:01:40.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":406,"price":17.7495,"value":7206.297,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 936 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 15,964 RSUs."}],"balance_after":20405,"source":{"system":"sec-edgar","filing":"0001567619-22-013250","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922013250/doc1.xml","form_type":"4"}},{"id":2323216,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-22T00:01:24.000Z","date":"2022-03-17","kind":"sale","acquired":false,"shares":159,"price":18.6162,"value":2959.9758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $18.32 to $18.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 17,151 RSUs."}],"balance_after":19875,"source":{"system":"sec-edgar","filing":"0001567619-22-007323","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922007323/doc1.xml","form_type":"4"}},{"id":2355017,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:26:32.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":40600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2022 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":40600,"derivative":{"exercise_price":18.56,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":40600},"source":{"system":"sec-edgar","filing":"0001567619-22-006234","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922006234/doc1.xml","form_type":"4"}},{"id":2355016,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T21:26:32.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 17,613 Restricted Stock Units."}],"balance_after":20034,"source":{"system":"sec-edgar","filing":"0001567619-22-006234","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761922006234/doc1.xml","form_type":"4"}},{"id":2462583,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-21T21:34:15.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":170,"price":24.41,"value":4149.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 412 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,013 RSUs."}],"balance_after":8434,"source":{"system":"sec-edgar","filing":"0001567619-21-022406","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761921022406/doc1.xml","form_type":"4"}},{"id":2563126,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-21T23:48:46.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":166,"price":30.02,"value":4983.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,475 RSUs."}],"balance_after":8192,"source":{"system":"sec-edgar","filing":"0001567619-21-017417","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761921017417/doc1.xml","form_type":"4"}},{"id":2659058,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-22T21:16:50.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":160,"price":34.1241,"value":5459.856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $33.66 to $34.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 614 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 6,938 RSUs."}],"balance_after":8358,"source":{"system":"sec-edgar","filing":"0001567619-21-012487","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761921012487/doc1.xml","form_type":"4"}},{"id":2803441,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-09T00:42:03.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":25900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 4, 2021 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":25900,"derivative":{"exercise_price":42.45,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":25900},"source":{"system":"sec-edgar","filing":"0001567619-21-005847","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761921005847/doc1.xml","form_type":"4"}},{"id":2803440,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-09T00:42:03.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":7400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,400 Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 504 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":7904,"source":{"system":"sec-edgar","filing":"0001567619-21-005847","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761921005847/doc1.xml","form_type":"4"}},{"id":3006420,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-15T23:14:56.000Z","date":"2020-10-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vest on the first anniversary measured from August 16, 2018 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":62201,"derivative":{"exercise_price":2.68,"expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-20-017887","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920017887/doc1.xml","form_type":"4"}},{"id":3006419,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-15T23:14:56.000Z","date":"2020-10-13","kind":"sale","acquired":false,"shares":10000,"price":44,"value":440000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-017887","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920017887/doc1.xml","form_type":"4"}},{"id":3006418,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-15T23:14:56.000Z","date":"2020-10-13","kind":"exercise","acquired":true,"shares":10000,"price":2.68,"value":26800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-20-017887","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920017887/doc1.xml","form_type":"4"}},{"id":3010186,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-08T21:07:07.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vest on the first anniversary measured from August 16, 2018 (the \"Vesting Commencement Date\") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":72201,"derivative":{"exercise_price":2.68,"expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-20-017693","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920017693/doc1.xml","form_type":"4"}},{"id":3010185,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-08T21:07:07.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":10000,"price":40,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-017693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920017693/doc1.xml","form_type":"4"}},{"id":3010184,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-08T21:07:07.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":10000,"price":2.68,"value":26800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-20-017693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920017693/doc1.xml","form_type":"4"}},{"id":3270886,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35163,"kind":"person","name":"Anders Jack","position":1,"cik":"0001800668","reported_name":"Anders Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T21:21:49.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":17467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/48 of the shares subject thereto on each monthly anniversary of February 12, 2020, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":17467,"derivative":{"exercise_price":17,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":17467},"source":{"system":"sec-edgar","filing":"0001567619-20-004010","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800668/000156761920004010/doc1.xml","form_type":"4"}}]}